Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival-Reference-Cited by-同舟云学术

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Published:2004-08-22 Issue:9 Volume:10 Page:942-949
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Curiel Tyler J,Coukos George,Zou Linhua,Alvarez Xavier,Cheng Pui,Mottram Peter,Evdemon-Hogan Melina,Conejo-Garcia Jose R,Zhang Lin,Burow Matthew,Zhu Yun,Wei Shuang,Kryczek Ilona,Daniel Ben,Gordon Alan,Myers Leann,Lackner Andrew,Disis Mary L,Knutson Keith L,Chen Lieping,Zou Weiping

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1093.pdf

Reference48 articles.

1. Romero, P. et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188, 1641–1650 (1998).

2. Lee, P.P. et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5, 677–685 (1999).

3. Salio, M. et al. Mature dendritic cells prime functionally superior melan-A–specific CD8+ lymphocytes as compared with nonprofessional APC. J. Immunol. 167, 1188–1197 (2001).

4. Dunbar, P.R. et al. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J. Immunol. 165, 6644–6652 (2000).

5. Curiel, T.J. et al. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity. Nat. Med. 9, 562–567 (2003).

Cited by 4242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL22 as an independent prognostic factor in endometrial cancer patients;Translational Oncology;2024-12

2. Tryptanthrin targets GSTP1 to induce senescence and increases the susceptibility to apoptosis by senolytics in liver cancer cells;Redox Biology;2024-10

3. Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways;Molecular Oncology;2024-09-08

4. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04

5. Immunological hide-and-seek: epigenetically reprogrammed cancer cells and the dynamics of CD8+ T cells;Molecular Biology Reports;2024-09-04